Siloam International Hospitals
PT Siloam International Hospitals Tbk operates hospitals and clinics in Indonesia. The company offers general, pre-marital, and lite checkups; male and female screenings; heart, kidney, and cancer screenings; visa application and preemployment screenings; and vaccine and genomic testing services. It also provides diagnostic services, including laboratory and radiology checks; home services; COVID… Read more
Siloam International Hospitals (SILO) - Net Assets
Latest net assets as of June 2025: Rp9.25 Trillion IDR
Based on the latest financial reports, Siloam International Hospitals (SILO) has net assets worth Rp9.25 Trillion IDR as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rp13.53 Trillion) and total liabilities (Rp4.28 Trillion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rp9.25 Trillion |
| % of Total Assets | 68.38% |
| Annual Growth Rate | 34.53% |
| 5-Year Change | 45.42% |
| 10-Year Change | 402.98% |
| Growth Volatility | 144.32 |
Siloam International Hospitals - Net Assets Trend (2010–2024)
This chart illustrates how Siloam International Hospitals's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Siloam International Hospitals (2010–2024)
The table below shows the annual net assets of Siloam International Hospitals from 2010 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | Rp8.75 Trillion | +8.75% |
| 2023-12-31 | Rp8.05 Trillion | +14.13% |
| 2022-12-31 | Rp7.05 Trillion | +8.09% |
| 2021-12-31 | Rp6.52 Trillion | +8.40% |
| 2020-12-31 | Rp6.02 Trillion | +0.51% |
| 2019-12-31 | Rp5.99 Trillion | -5.21% |
| 2018-12-31 | Rp6.32 Trillion | +0.05% |
| 2017-12-31 | Rp6.31 Trillion | +101.77% |
| 2016-12-31 | Rp3.13 Trillion | +79.84% |
| 2015-12-31 | Rp1.74 Trillion | +5.22% |
| 2014-12-31 | Rp1.65 Trillion | +0.90% |
| 2013-12-31 | Rp1.64 Trillion | +569.96% |
| 2012-12-31 | Rp244.64 Billion | +36.70% |
| 2011-12-31 | Rp178.96 Billion | +30.08% |
| 2010-12-31 | Rp137.58 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Siloam International Hospitals's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 4379.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Rp2.78 Trillion | 32.43% |
| Common Stock | Rp162.58 Billion | 1.90% |
| Other Comprehensive Income | Rp-80.11 Billion | -0.93% |
| Other Components | Rp5.71 Trillion | 66.61% |
| Total Equity | Rp8.57 Trillion | 100.00% |
Siloam International Hospitals Competitors by Market Cap
The table below lists competitors of Siloam International Hospitals ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Oak Valley Bancorp
NASDAQ:OVLY
|
$226.74 Million |
|
IEI Integration Corp
TW:3022
|
$226.74 Million |
|
Guangzheng Group Co Ltd
SHE:002524
|
$226.79 Million |
|
Xinjiang Sayram Modern Agriculture Co Ltd
SHG:600540
|
$226.80 Million |
|
Shanghai Wisdom Information Technology Co. Ltd.
SHE:301315
|
$226.57 Million |
|
MiCo Ltd
KQ:059090
|
$226.55 Million |
|
SIM Acquisition Corp. I Unit
NASDAQ:SIMAU
|
$226.53 Million |
|
Shan Dong Delisi Food Co Ltd
SHE:002330
|
$226.44 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Siloam International Hospitals's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 7,915,639,000,000 to 8,569,819,000,000, a change of 654,180,000,000 (8.3%).
- Net income of 902,152,000,000 contributed positively to equity growth.
- Dividend payments of 259,645,000,000 reduced retained earnings.
- Share repurchases of 23,726,000,000 reduced equity.
- New share issuances of 56,280,000,000 increased equity.
- Other comprehensive income decreased equity by 40,247,000,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rp902.15 Billion | +10.53% |
| Dividends Paid | Rp259.64 Billion | -3.03% |
| Share Repurchases | Rp23.73 Billion | -0.28% |
| Share Issuances | Rp56.28 Billion | +0.66% |
| Other Comprehensive Income | Rp-40.25 Billion | -0.47% |
| Other Changes | Rp19.37 Billion | +0.23% |
| Total Change | Rp- | 8.26% |
Book Value vs Market Value Analysis
This analysis compares Siloam International Hospitals's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.20x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 162.43x to 4.20x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2010-12-31 | Rp16.99 | Rp2760.00 | x |
| 2011-12-31 | Rp22.34 | Rp2760.00 | x |
| 2012-12-31 | Rp28.51 | Rp2760.00 | x |
| 2013-12-31 | Rp188.16 | Rp2760.00 | x |
| 2014-12-31 | Rp174.30 | Rp2760.00 | x |
| 2015-12-31 | Rp185.16 | Rp2760.00 | x |
| 2016-12-31 | Rp329.41 | Rp2760.00 | x |
| 2017-12-31 | Rp574.07 | Rp2760.00 | x |
| 2018-12-31 | Rp483.35 | Rp2760.00 | x |
| 2019-12-31 | Rp456.81 | Rp2760.00 | x |
| 2020-12-31 | Rp458.90 | Rp2760.00 | x |
| 2021-12-31 | Rp497.09 | Rp2760.00 | x |
| 2022-12-31 | Rp704.92 | Rp2760.00 | x |
| 2023-12-31 | Rp607.24 | Rp2760.00 | x |
| 2024-12-31 | Rp657.23 | Rp2760.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Siloam International Hospitals utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 10.53%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 7.39%
- • Asset Turnover: 0.86x
- • Equity Multiplier: 1.66x
- Recent ROE (10.53%) is above the historical average (10.15%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2010 | 48.55% | 6.55% | 1.32x | 5.61x | Rp53.58 Billion |
| 2011 | 23.94% | 3.47% | 1.13x | 6.09x | Rp25.47 Billion |
| 2012 | 21.64% | 2.82% | 1.13x | 6.80x | Rp27.14 Billion |
| 2013 | 3.09% | 1.99% | 0.96x | 1.61x | Rp-111.27 Billion |
| 2014 | 3.80% | 1.87% | 1.17x | 1.73x | Rp-102.25 Billion |
| 2015 | 4.04% | 1.70% | 1.39x | 1.71x | Rp-104.01 Billion |
| 2016 | 2.75% | 1.66% | 1.23x | 1.35x | Rp-226.29 Billion |
| 2017 | 1.49% | 1.60% | 0.77x | 1.21x | Rp-535.70 Billion |
| 2018 | 0.26% | 0.27% | 0.78x | 1.22x | Rp-612.47 Billion |
| 2019 | -5.60% | -4.74% | 0.91x | 1.30x | Rp-927.13 Billion |
| 2020 | 1.95% | 1.63% | 0.84x | 1.41x | Rp-480.11 Billion |
| 2021 | 10.46% | 7.19% | 1.01x | 1.44x | Rp29.90 Billion |
| 2022 | 10.01% | 7.32% | 0.98x | 1.39x | Rp947.10 Million |
| 2023 | 15.30% | 10.82% | 1.02x | 1.39x | Rp419.72 Billion |
| 2024 | 10.53% | 7.39% | 0.86x | 1.66x | Rp45.17 Billion |
Industry Comparison
This section compares Siloam International Hospitals's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $3,727,317,217,832
- Average return on equity (ROE) among peers: 25.33%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Siloam International Hospitals (SILO) | Rp9.25 Trillion | 48.55% | 0.46x | $226.65 Million |
| Bundamedik Tbk PT (BMHS) | $665.59 Billion | 4.71% | 1.10x | $23.76 Million |
| Metro Healthcare Indonesia (CARE) | $3.30 Trillion | 0.18% | 0.28x | $411.41 Million |
| Medikaloka Hermina PT (HEAL) | $2.37 Trillion | 5.25% | 0.76x | $810.80 Million |
| Lippo Karawaci Tbk (LPKR) | $23.57 Trillion | -40.88% | 1.20x | $179.43 Million |
| Mitra Keluarga Karyasehat Tbk PT (MIKA) | $3.28 Trillion | 17.29% | 0.13x | $602.27 Million |
| PT Murni Sadar Tbk (MTMH) | $50.49 Billion | 4.95% | 14.96x | $27.98 Million |
| Famon Awal Bros Sedaya (PRAY) | $3.13 Trillion | 6.43% | 0.62x | $52.90 Million |
| Royal Prima PT (PRIM) | $722.89 Million | 252.77% | 36.50x | $3.23 Million |
| PT Charlie Hospital Semarang Tbk (RSCH) | $150.46 Billion | -0.74% | 0.03x | $11.66 Million |
| Kedoya Adyaraya Tbk PT (RSGK) | $751.16 Billion | 3.35% | 0.10x | $3.08 Million |